Letters to the editor
MAFLD or MASLD: Let the evidence decide again
Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia
Read
659
Timeswas read the article
106
Total PDF
553
Total HTML
Share statistics
array:23 [ "pii" => "S1665268124003156" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101521" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "101521" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2024;29:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S1665268124003211" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101527" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "101527" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2024;29:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "MAFLD vs. MASLD: Consensus is unlike evidence!" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Enas Kamal, Alaa M Mostafa, Yasser Fouad" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Enas" "apellidos" => "Kamal" ] 1 => array:2 [ "nombre" => "Alaa M" "apellidos" => "Mostafa" ] 2 => array:2 [ "nombre" => "Yasser" "apellidos" => "Fouad" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124003211?idApp=UINPBA00004N" "url" => "/16652681/0000002900000005/v1_202408300521/S1665268124003211/v1_202408300521/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1665268124003247" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101530" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "101530" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Ann Hepatol. 2024;29:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0001" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1420 "Ancho" => 2833 "Tamanyo" => 272704 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Scaffold obtained by electrospinning</span>. A), fibers collected in dynamic collector. B), 2–3 cm sections for mechanical-biological evaluations. C) End-to-end anastomosis: common bile duct-prosthesis-common bile duct.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alan I. Valderrama-Treviño, Andrés E. Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A. Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, Natalia Nuño-Lámbarri, Eduardo E. Montalvo-Javé" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Alan I." "apellidos" => "Valderrama-Treviño" ] 1 => array:2 [ "nombre" => "Andrés E." "apellidos" => "Castell-Rodríguez" ] 2 => array:2 [ "nombre" => "Rolando" "apellidos" => "Hernández-Muñoz" ] 3 => array:2 [ "nombre" => "Nadia A." "apellidos" => "Vázquez-Torres" ] 4 => array:2 [ "nombre" => "Andrés" "apellidos" => "Macari-Jorge" ] 5 => array:2 [ "nombre" => "Baltazar" "apellidos" => "Barrera-Mera" ] 6 => array:2 [ "nombre" => "Alfredo" "apellidos" => "Maciel-Cerda" ] 7 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Vera-Graziano" ] 8 => array:2 [ "nombre" => "Natalia" "apellidos" => "Nuño-Lámbarri" ] 9 => array:2 [ "nombre" => "Eduardo E." "apellidos" => "Montalvo-Javé" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124003247?idApp=UINPBA00004N" "url" => "/16652681/0000002900000005/v1_202408300521/S1665268124003247/v1_202408300521/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "MAFLD or MASLD: Let the evidence decide again" "tieneTextoCompleto" => true "saludo" => "To the Editor:" "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Ziyan Pan, Mohammed Eslam" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Ziyan" "apellidos" => "Pan" ] 1 => array:4 [ "nombre" => "Mohammed" "apellidos" => "Eslam" "email" => array:1 [ 0 => "mohammed.eslam@sydney.edu.au" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0001" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia" "identificador" => "aff0001" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0001" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="para0001" class="elsevierStylePara elsevierViewall">We thank Ramírez-Mejíaa <span class="elsevierStyleItalic">et al</span>. [<a class="elsevierStyleCrossRef" href="#bib0001">1</a>] and Kamal <span class="elsevierStyleItalic">et al</span>. [<a class="elsevierStyleCrossRef" href="#bib0002">2</a>] for their interest and comments on our work [<a class="elsevierStyleCrossRef" href="#bib0003">3</a>]. A discussion about the redefinition of the most common liver disease, fatty liver disease due to metabolic dysfunction is still actively ongoing. Ramírez-Mejíaa <span class="elsevierStyleItalic">et al</span>. emphasize that time will ultimately determine the outcome of this discussion and any new version of diagnostic criteria must present significant conceptual advances over previous ones to be accepted.</p><p id="para0002" class="elsevierStylePara elsevierViewall">Kamal <span class="elsevierStyleItalic">et al.</span> expressed concerns about the recently proposed definition of metabolic dysfunction-associated steatotic liver disease (MASLD) and the process that led to this outcome. They underscore the importance of distinguishing between consensus and evidence, the controversy surrounding the term and concept of MetALD [<a class="elsevierStyleCrossRef" href="#bib0004">4</a>,<a class="elsevierStyleCrossRef" href="#bib0005">5</a>], and question how changing "F" to "S" from metabolic dysfunction-associated fatty liver disease (MAFLD) to MASLD addressed previous concerns about the MAFLD definition. They also advocate for editorial flexibility when dealing with various disease nomenclatures.</p><p id="para0003" class="elsevierStylePara elsevierViewall">Debates are inevitable in research, but they can only be resolved by relying on robust evidence rather than an eminence-based approach [<a class="elsevierStyleCrossRef" href="#bib0006">6</a>]. Within a short period, a significant amount of evidence has quickly accumulated, confirming that the definition of MAFLD identifies a more uniform group of patients with fatty liver caused by metabolic dysfunction. This surpasses not only the previous non-alcoholic fatty liver disease (NAFLD) definition but also the recently suggested MASLD definition. Therefore, MAFLD is currently the best available definition for this disease to date [<a class="elsevierStyleCrossRefs" href="#bib0007">7–12</a>]. MAFLD presents a meaningful conceptual framework and practical definition and for approaching the disease and developing a patient-centred holistic approach to management considering multiple driving modes, with the ultimate aim of enhancing health outcomes. The emerging research signifies the beginning of a new era in reshaping the ongoing discussion by obtaining the essential evidence that will resolve the debate and open up new paths for further research. The only way to move forward is through additional studies and evidence.</p><p id="para0004" class="elsevierStylePara elsevierViewall">In conclusion, the insights shared by Ramírez-Mejíaa <span class="elsevierStyleItalic">et al</span>. [<a class="elsevierStyleCrossRef" href="#bib0001">1</a>] and Kamal <span class="elsevierStyleItalic">et al</span>. [<a class="elsevierStyleCrossRef" href="#bib0002">2</a>] emphasize the importance of distinguishing between "evidence" and "opinion" in the field of medicine. It is crucial to engage in discussions and prioritize gathering evidence to resolve debates. Once robust evidence is available, it should guide our directions.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2024-05-23" "fechaAceptado" => "2024-05-23" "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec1" "bibliografiaReferencia" => array:12 [ 0 => array:3 [ "identificador" => "bib0001" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "NAFLD-MASLD-MAFLD continuum: a swinging pendulum?" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Ramírez-Mejíaa" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2024" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0002" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MAFLD vs. MASLD: consensus is unlike evidence!" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "E. Kamal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2024" "itemHostRev" => array:3 [ "pii" => "S0168822716301553" "estado" => "S300" "issn" => "01688227" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0003" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Z. Pan" 1 => "M. Derbala" 2 => "K. AlNaamani" 3 => "H. Ghazinian" 4 => "J.G. Fan" 5 => "M. Eslam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.aohep.2024.101512" "Revista" => array:2 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2024" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0004" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "What the new definition of MASLD left behind: dual etiology with viral hepatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y. Fouad" 1 => "F. Sanai" 2 => "M. Alboraie" 3 => "M.H. Zheng" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2023.11.026" "Revista" => array:2 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2023" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0005" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MetALD: The outcome of living under the shadow of alcohol for 4 decades" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.M.M. Méndez-Sánchez N" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2024.05.009" "Revista" => array:2 [ "tituloSerie" => "CGH" "fecha" => "2024" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0006" "etiqueta" => "[6]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The NAFLD-MAFLD debate: eminence vs evidence" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Fouad" 1 => "R. Elwakil" 2 => "M. Elsahhar" 3 => "E. Said" 4 => "S. Bazeed" 5 => "A. Ali Gomaa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/liv.14739" "Revista" => array:7 [ "tituloSerie" => "Liver Int" "fecha" => "2021" "volumen" => "41" "numero" => "2" "paginaInicial" => "255" "paginaFinal" => "260" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33220154" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0007" "etiqueta" => "[7]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metabolic dysfunction-associated fatty liver disease: a year in review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Alharthi" 1 => "A. Gastaldelli" 2 => "I.H. Cua" 3 => "H. Ghazinian" 4 => "M. Eslam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MOG.0000000000000823" "Revista" => array:7 [ "tituloSerie" => "Curr Opin Gastroenterol" "fecha" => "2022" "volumen" => "38" "numero" => "3" "paginaInicial" => "251" "paginaFinal" => "260" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35143431" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0008" "etiqueta" => "[8]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MAFLD identifies patients with significant hepatic fibrosis better than MASLD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Z. Pan" 1 => "S.A. Al-Busafi" 2 => "M. Abdulla" 3 => "Y. Fouad" 4 => "G. Sebastiani" 5 => "M. Eslam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12072-024-10673-7" "Revista" => array:4 [ "tituloSerie" => "Hepatol Int" "fecha" => "2024" "paginaInicial" => "1" "paginaFinal" => "9" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0009" "etiqueta" => "[9]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The MASLD criteria overlook a number of adolescent patients with severe steatosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Z. Pan" 1 => "M. Eslam" 2 => "A. Choudhury" 3 => "B. Sahoo" 4 => "C.R. Lesmana" 5 => "FM. Sanai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2024.03.042" "Revista" => array:2 [ "tituloSerie" => "J Hepatol" "fecha" => "2024" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0010" "etiqueta" => "[10]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MAFLD predicts cardiovascular disease risk better than MASLD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Z. Pan" 1 => "G. Shiha" 2 => "G. Esmat" 3 => "N. Méndez-Sánchez" 4 => "M. Eslam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/liv.15931" "Revista" => array:2 [ "tituloSerie" => "Liver Int" "fecha" => "2024" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0011" "etiqueta" => "[11]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.M. Ramírez-Mejía" 1 => "C. Jiménez-Gutiérrez" 2 => "M. Eslam" 3 => "J. George" 4 => "N. Méndez-Sánchez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12072-023-10620-y" "Revista" => array:6 [ "tituloSerie" => "Hepatol Int" "fecha" => "2024" "volumen" => "18" "numero" => "1" "paginaInicial" => "168" "paginaFinal" => "178" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0012" "etiqueta" => "[12]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "WMU MAFLD Clinical Research Working Group" "etal" => false "autores" => array:5 [ 0 => "X.D. Zhou" 1 => "A. Lonardo" 2 => "C.Q. Pan" 3 => "M.D. Shapiro" 4 => "M.H. Zheng" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2024.03.039" "Revista" => array:2 [ "tituloSerie" => "J Hepatol" "fecha" => "2024" ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack769356" "titulo" => "Acknowledgments" "texto" => "<p id="para0006" class="elsevierStylePara elsevierViewall">ME is supported by a National Health and Medical Research Council of Australia (<span class="elsevierStyleGrantSponsor" id="gs0001">National Cancer Institute NHMRC</span>) Program Grant (<span class="elsevierStyleGrantNumber" refid="gs0001">APP1053206</span>) and Project and Ideas grants (<span class="elsevierStyleGrantNumber" refid="gs0001">APP2001692</span>, <span class="elsevierStyleGrantNumber" refid="gs0001">APP1107178</span> and <span class="elsevierStyleGrantNumber" refid="gs0001">APP1108422</span>).</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000002900000005/v1_202408300521/S1665268124003156/v1_202408300521/en/main.assets" "Apartado" => array:4 [ "identificador" => "82754" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000002900000005/v1_202408300521/S1665268124003156/v1_202408300521/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124003156?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 18 | 1 | 19 |
| 2024 October | 110 | 7 | 117 |
| 2024 September | 140 | 29 | 169 |
| 2024 August | 98 | 24 | 122 |
| 2024 July | 83 | 19 | 102 |
| 2024 June | 104 | 26 | 130 |
